Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

Richard A Hansen1, Gerald Gartlehner2, Aaron P Webb1, Laura C Morgan3, Charity G Moore4, Daniel E Jonas31School of Pharmacy, 3Cecil G Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA; 2Department for Evidence-based Medicine and Clinical Epidemiology, Danu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Richard A Hansen, Gerald Gartlehner, Aaron P Webb, Laura C Morgan, Charity G Moore, Daniel E Jonas
Format: article
Langue:EN
Publié: Dove Medical Press 2008
Sujets:
Accès en ligne:https://doaj.org/article/d5c15d92899e49d28e97a25f7619b761
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!